ATHEROSCLEROTIC CARDIOVASCULAR DISEASE (ASCVD)
Clinical trials for ATHEROSCLEROTIC CARDIOVASCULAR DISEASE (ASCVD) explained in plain language.
Never miss a new study
Get alerted when new ATHEROSCLEROTIC CARDIOVASCULAR DISEASE (ASCVD) trials appear
Sign up with your email to follow new studies for ATHEROSCLEROTIC CARDIOVASCULAR DISEASE (ASCVD), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Massive study reveals Semaglutide's heart benefits in overweight people
Disease control CompletedThis study looked at whether a once-weekly medicine called semaglutide can lower the risk of heart problems and other obesity-related health issues in people with overweight or obesity. Researchers analyzed medical records from over 285,000 people in the U.S. to see how semagluti…
Matched conditions: ATHEROSCLEROTIC CARDIOVASCULAR DISEASE (ASCVD)
Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated May 17, 2026 15:39 UTC
-
Prostate pill may shield heart: 10,000-Person study hints at surprising benefit
Knowledge-focused CompletedThis study looked at whether a common prostate medication (5-alpha reductase inhibitors) might also lower the risk of heart disease in men with an enlarged prostate. Researchers analyzed health records from over 10,000 people in the UK and China. The goal was to see if these drug…
Matched conditions: ATHEROSCLEROTIC CARDIOVASCULAR DISEASE (ASCVD)
Sponsor: Chinese PLA General Hospital • Aim: Knowledge-focused
Last updated May 12, 2026 13:43 UTC
-
Doctors polled on hidden inflammation link in heart and kidney patients
Knowledge-focused CompletedThis study surveyed 1,500 heart and kidney specialists in China to understand how they think about inflammation in patients with both heart disease and chronic kidney disease. The goal was to learn what doctors know and do about inflammation in these patients. No treatments or te…
Matched conditions: ATHEROSCLEROTIC CARDIOVASCULAR DISEASE (ASCVD)
Sponsor: Novo Nordisk A/S • Aim: Knowledge-focused
Last updated May 11, 2026 20:52 UTC